Home » Topics » BioWorld Science

BioWorld Science
RSS

DE Shaw Research and Relay Therapeutics describe new PTP-1D inhibitors

Sep. 17, 2019

Sumitomo Dainippon Pharma presents dopamine D1 and D2 receptor antagonists

Sep. 17, 2019

Stanford University patents GPAM inhibitors

Sep. 17, 2019

Phase II data presented for selatogrel in patients with acute myocardial infarction

Sep. 17, 2019

B cells, T cells honored as hybrids reported

Sep. 17, 2019

miR-744 found to be a prognostic factor in NSCLC

Sep. 17, 2019

YK-4-279 and TK-216 show promising preclinical activity in models of lymphoma

Sep. 17, 2019

Discovery of novel PS-targeting zinc dipicolylamine-based drug conjugates

Sep. 17, 2019

Preliminary clinical data presented from U.S. phase II study of ANAVEX 2-73 in Rett syndrome

Sep. 17, 2019

Precision BioSciences announces FDA clearance of IND for PBCAR-20-A

Sep. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...